Biochemicals and Reagents
Biochemicals and reagents are fundamental substances for research and development in fields such as biotechnology, molecular biology, pharmacology, and medicine. These products are essential for a variety of applications, including compound synthesis, biological sample analysis, metabolic process research, and drug production. At CymitQuimica, we offer a wide selection of high-quality, high-purity biochemicals and reagents suitable for various scientific and industrial needs. Our catalog includes enzymes, antibodies, nucleic acids, amino acids, and many other products, all designed to support researchers and professionals in their research and development projects, ensuring reliable and reproducible results.
Subcategories of "Biochemicals and Reagents"
- Biomolecules(99,117 products)
- By Biological Target(99,161 products)
- By Pharmacological Effects(6,787 products)
- Cryopreservatives(21 products)
- Desinfectants and Related Compounds(28 products)
- Hormones(346 products)
- Plant Biology(6,710 products)
- Secondary Metabolites(14,222 products)
Found 130581 products of "Biochemicals and Reagents"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
[Tyr27]-pTH (27-48) (human)
<p>Catalogue peptide; min. 95% purity</p>Formula:C104H159N29O31Molecular weight:2,311.60 g/molOdevixibat
CAS:<p>Odevixibat is a pharmacological agent that functions as an ileal bile acid transport inhibitor, which is synthesized through complex organic chemistry methods to create a specific molecular structure targeting bile acid transport mechanisms. It works by inhibiting the apical sodium-dependent bile acid transporter (ASBT) in the terminal ileum. This action reduces the reabsorption of bile acids from the small intestine back into the liver, thereby reducing overall bile acid levels in the body.</p>Formula:C37H48N4O8S2Purity:Min. 95%Color and Shape:PowderMolecular weight:740.93 g/molAmyloid β-Protein (20-29) trifluoroacetate salt
CAS:<p>Please enquire for more information about Amyloid beta-Protein (20-29) trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C43H66N12O17Purity:Min. 95%Molecular weight:1,023.05 g/molA-A-A-Y-G-G-F-L
<p>Catalogue peptide; min. 95% purity</p>Formula:C37H52N8O10Molecular weight:768.87 g/molHypertrehalosaemic Neuropeptide, Nauphoeta cinerea
<p>Catalogue peptide; min. 95% purity</p>Formula:C50H67N13O14Molecular weight:1,074.19 g/molCarassin (Carrassius Auratus)
<p>Catalogue peptide; min. 95% purity</p>Formula:C103H175N35O27SMolecular weight:2,367.83 g/molDynorphin A (2-13), porcine
<p>Catalogue peptide; min. 95% purity</p>Formula:C66H117N23O13Molecular weight:1,440.81 g/mol[Val5,Asn9]-Angiotensin I
<p>Catalogue peptide; min. 95% purity</p>Formula:C59H86N16O15Molecular weight:1,259.44 g/molPrepro-adrenomedullin (153-185), human
<p>Catalogue peptide; min. 95% purity</p>Formula:C143H224N42O43Molecular weight:3,219.56 g/molAmyloid β-Protein (1-40) (scrambled) trifluoroacetate salt
CAS:<p>Please enquire for more information about Amyloid beta-Protein (1-40) (scrambled) trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C194H295N53O58SPurity:Min. 95%Molecular weight:4,329.81 g/molMyosin Kinase Inhibiting Peptide
<p>Catalogue peptide; min. 95% purity</p>Formula:C40H78N18O11Molecular weight:987.2 g/molBiotin-Kinase Domain of Insulin Receptor (2)
<p>Catalogue peptide; min. 95% purity</p>Formula:C72H122N21O29SMolecular weight:1,777.92 g/molβ-Amyloid (31-35)
<p>Catalogue peptide; min. 95% purity</p>Formula:C25H47N5O6SMolecular weight:545.75 g/molHPV-E7-C
<p>Catalogue peptide; min. 95% purity</p>Formula:C83H128N24O40Molecular weight:2,102.04 g/molLocustachykinin I
<p>Catalogue peptide; min. 95% purity</p>Formula:C43H63N13O11Molecular weight:938 g/molLKRApYLG-NH2
<p>Catalogue peptide; min. 95% purity</p>Formula:C38H67N12O11PMolecular weight:899.03 g/molMurine CMV pp 89 (170-174)
<p>Catalogue peptide; min. 95% purity</p>Formula:C29H41N7O7SMolecular weight:631.76 g/molBiotin-Secretin, human
<p>Catalogue peptide; min. 95% purity</p>Formula:C140H234N46O42SMolecular weight:5,465.80 g/molabII probe
<p>Catalogue peptide; min. 95% purity</p>Formula:C63H101N19O19SMolecular weight:1,460.69 g/molBiotin-[Glu1]-Gastrin I (human) (phosphorylated)
<p>Catalogue peptide; min. 95% purity</p>Formula:C107H141N22O37PS2Molecular weight:2,422.53 g/molDynorphin A (3-13), porcine
<p>Catalogue peptide; min. 95% purity</p>Formula:C64H114N22O12Molecular weight:1,383.76 g/mol[D-Pro10]-Dynorphin A (1-11), porcine
<p>Catalogue peptide; min. 95% purity</p>Formula:C63H103N21O13Molecular weight:1,362.66 g/molAmyloid Dan Protein (1-34)
<p>Catalogue peptide; min. 95% purity</p>Formula:C185H268N48O51S2Molecular weight:4,044.63 g/molβ-Endorphin (1-5), (16-31), human
<p>Catalogue peptide; min. 95% purity</p>Formula:C112H173N27O29SMolecular weight:2,393.86 g/mol[Tyr12]-Somatostatin-28 (1-14)
<p>Catalogue peptide; min. 95% purity</p>Formula:C65H107N23O20SMolecular weight:1,562.78 g/molAcyl Carrier Protein (65-74) (acid)
<p>Catalogue peptide; min. 95% purity</p>Formula:C47H74N12O16Molecular weight:1,063.18 g/molβ-Amyloid/A4 Protein Precusor (APP) (319-335)
<p>Catalogue peptide; min. 95% purity</p>Formula:C86H151N31O26S2Molecular weight:2,099.48 g/molα-Melanocyte Stimulating Hormone [Acetyl-D-Lys11, D-Val13] (11-13) (MSHa)
<p>Catalogue peptide; min. 95% purity</p>Formula:C18H33N5O4Molecular weight:383.49 g/molAllatostatin VII
<p>Catalogue peptide; min. 95% purity</p>Formula:C46H69N13O13SMolecular weight:1,044.2 g/molParallel topology β-Amyloid modified peptide
<p>Catalogue peptide; min. 95% purity</p>Formula:C151H211N37O39SMolecular weight:3,199.65 g/molIL-8ra (9-29)
<p>Catalogue peptide; min. 95% purity</p>Formula:C112H150N24O38S2Molecular weight:2,504.71 g/molOrn8, Urotensin II, human
<p>Catalogue peptide; min. 95% purity</p>Formula:C63H85N13O18S2Molecular weight:1,376.60 g/molAc-β-Endorphin, bovine, camel, ovine
<p>Catalogue peptide; min. 95% purity</p>Formula:C157H252N42O45SMolecular weight:3,479.99 g/molDynorphin A (1-11), porcine
<p>Catalogue peptide; min. 95% purity</p>Formula:C63H103N21O13Molecular weight:1,362.66 g/molβ-Interleukin I (163-171), human
<p>Catalogue peptide; min. 95% purity</p>Formula:C39H64N12O19Molecular weight:1,005.01 g/molLeucopyrokinin (LPK)
<p>Catalogue peptide; min. 95% purity</p>Formula:C42H66N12O12Molecular weight:931.06 g/molα-Casein (90-95)
<p>Catalogue peptide; min. 95% purity</p>Formula:C103H175N35O27SMolecular weight:2,367.83 g/molEMP-1 (Epithelial Membrane Protein)
<p>Catalogue peptide; min. 95% purity</p>Formula:C94H133N25O26S2Molecular weight:2,093.39 g/molNeuropeptide Y-Lys(Biotin), human, rat
<p>Catalogue peptide; min. 95% purity</p>Formula:C199H300N57O60S2Molecular weight:4,514.98 g/molBig Gastrin-1, human
<p>Catalogue peptide; min. 95% purity</p>Formula:C176H251N43O53SMolecular weight:3,849.30 g/mol[D-Val22, Phe33] Big Endothelin-1 (16-38), human
<p>Catalogue peptide; min. 95% purity</p>Formula:C122H178N32O33Molecular weight:2,620.97 g/molBoc-N-Me-D-Tyr-OH·DCHA
CAS:Controlled Product<p>Please enquire for more information about Boc-N-Me-D-Tyr-OH·DCHA including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C15H21NO5·C12H23NPurity:Min. 95%Molecular weight:476.65 g/molHPV-E6-N
<p>Catalogue peptide; min. 95% purity</p>Formula:C76H128N24O25SMolecular weight:1,810.07 g/molDok-5 (263-275)
<p>Catalogue peptide; min. 95% purity</p>Formula:C75H114N24O19Molecular weight:1,655.89 g/molLHRH-Ⅲ, lamprey
<p>Catalogue peptide; min. 95% purity</p>Formula:C59H75N18O14Molecular weight:1,259.4 g/molAntho-Rwamide I
<p>Catalogue peptide; min. 95% purity</p>Formula:C31H46N10O7Molecular weight:670.79 g/molKinase Domain of Insulin Receptor (1)
<p>Catalogue peptide; min. 95% purity</p>Formula:C70H105N18O25PMolecular weight:1,629.72 g/molβ-Casomorphin (1-4) (bovine)
<p>Catalogue peptide; min. 95% purity</p>Formula:C28H34N4O6Molecular weight:522.61 g/molMMP Substrate I, fluorogenic
<p>Catalogue peptide; min. 95% purity</p>Formula:C45H64N14O11Molecular weight:977.1 g/molFibrinopeptide B
<p>Catalogue peptide; min. 95% purity</p>Formula:C66H93N19O25Molecular weight:1,552.60 g/molSturgeon F
<p>Catalogue peptide; min. 95% purity</p>Formula:C61H83N13O14SMolecular weight:1,254.48 g/mol[Tyr4]-Bombesin
<p>Catalogue peptide; min. 95% purity</p>Formula:C74H108N24O19S1Molecular weight:1,669.9 g/molβ III probe
<p>Catalogue peptide; min. 95% purity</p>Formula:C87H143N27O28S3Molecular weight:2,111.45 g/molBrain Derived Acidic Fibroblast Growth Factor (1-11)
<p>Catalogue peptide; min. 95% purity</p>Formula:C62H95N15O15Molecular weight:1,290.53 g/molMLC-derived peptide
<p>Catalogue peptide; min. 95% purity</p>Formula:C70H115N25O17Molecular weight:1,578.85 g/molLMP1 (156-164), IAL
<p>Catalogue peptide; min. 95% purity</p>Formula:C55H81N13O14Molecular weight:1,148.34 g/mol[Des-Tyr1]-g-Endorphin
<p>Catalogue peptide; min. 95% purity</p>Formula:C74H122N18O25SMolecular weight:1,695.97 g/molRC-160(Vapreotide)
<p>Catalogue peptide; min. 95% purity</p>Formula:C57H70N12O9S2Molecular weight:1,131.4 g/molP60c-src Substrate II, Phosphorylated
<p>Catalogue peptide; min. 95% purity</p>Formula:C33H45N6O12PMolecular weight:748.8 g/molNecrofibrin, human
<p>Catalogue peptide; min. 95% purity</p>Formula:C67H112N16O25Molecular weight:1,541.73 g/molPancreatic Polypeptide (31-36) (human)
<p>Catalogue peptide; min. 95% purity</p>Formula:C36H61N13O8Molecular weight:804 g/molZ-Asp-Gln-Met-Asp-AFC
CAS:<p>Please enquire for more information about Z-Asp-Gln-Met-Asp-AFC including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C36H39F3N6O13SPurity:Min. 95%Molecular weight:852.79 g/molFelodipine
CAS:<p>L-type calcium channel blocker; anti-hypertensive</p>Formula:C18H19Cl2NO4Purity:Min. 95%Color and Shape:White PowderMolecular weight:384.25 g/molNocistatin (Bovine)
CAS:<p>Nocistatin is a research tool that can be used in the study of protein interactions. It is a synthetic peptide that binds to receptor sites on cell membranes, which has been shown to inhibit ion channels and receptor-mediated signal transduction. Nocistatin (Bovine) has been shown to inhibit calcium ion channel activity and membrane depolarization by binding to the alpha1 subunit of GABA A receptors.</p>Formula:C82H135N21O32Purity:Min. 95%Molecular weight:1,927.1 g/molZ-Gly-Gly-Trp-OH TFA
CAS:<p>Please enquire for more information about Z-Gly-Gly-Trp-OH TFA including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C23H24N4O6•C2HF3O2Purity:Min. 95%Molecular weight:566.48 g/molDesmopressin
CAS:Controlled Product<p>Desmopressin is a synthetic analog of the natural hormone arginine vasopressin. It has been shown to be effective in the treatment of primary nocturnal enuresis, and a number of studies have reported that desmopressin is an effective therapy for idiopathic nocturnal enuresis. Desmopressin also has effects on water permeability, hemolysis, and protein synthesis. It increases the concentration of camp levels in urine and plasma while also inhibiting erythrocyte aggregation. Desmopressin has been shown to be more effective than placebo in women with primary nocturnal enuresis.</p>Formula:C46H64N14O12S2Purity:Min. 95%Color and Shape:PowderMolecular weight:1,069.22 g/molCalcitonin, eel
<p>Catalogue peptide; min. 95% purity</p>Formula:C146H241N43O47S2Molecular weight:3,414.94 g/mol[D-Arg0,Hyp2,3,D-Phe7]-Bradykinin
<p>Catalogue peptide; min. 95% purity</p>Formula:C60H87N19O14Molecular weight:1,298.48 g/molAvibactam descarbonyl
CAS:<p>Avibactam descarbonyl is a medicinal compound that has shown promise as an anticancer agent. It is an analog of kinase inhibitors, which are known to have potent anticancer activity. Avibactam descarbonyl has been shown to induce apoptosis in cancer cells and inhibit the growth of tumors in Chinese hamsters. This compound has also been found in urine samples from patients receiving avibactam therapy, suggesting that it may be a metabolite of this drug. Avibactam descarbonyl is a cyclin-dependent protein kinase inhibitor, which means that it can prevent the proliferation of cancer cells by blocking cell cycle progression. This compound has potential for use in cancer treatment due to its potent anticancer activity and ability to induce apoptosis in tumor cells.</p>Formula:C6H13N3O5SPurity:Min. 95%Molecular weight:239.25 g/molBNP (1-21), Pro (Human)
<p>Catalogue peptide; min. 95% purity</p>Formula:C89H144N28O35Molecular weight:2,166.31 g/molCID 16020046
CAS:<p>Puromycin is an aminonucleoside antibiotic, derived from the bacterium Streptomyces albus, with its primary mode of action involving the inhibition of protein synthesis. During translation, puromycin mimics the aminoacyl end of tRNA, enabling its incorporation into the growing polypeptide chain within the ribosome. This incorporation disrupts further chain elongation, ultimately leading to premature termination of protein synthesis.</p>Formula:C25H19N3O4Purity:Min. 95%Molecular weight:425.44 g/molEndothelin-1 (human, bovine, dog, mouse, porcine, rat) acetate
CAS:<p>Endothelin-1 (ET-1) is a peptide that is produced by the endothelium. ET-1 is involved in numerous biological processes, including vasoconstriction, inflammation, and cell proliferation. Endothelin-1 (human ET-1) acetate salt H-Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-(Glu)-Cys-(Val)-Tyr-(Phe)-Cys-(His)-Leu -Asp(-Ile)-Ile(-Trp)) acetate salt is a recombinant protein that has been shown to significantly upregulate the production of endothelin in primary pulmonary hypertension. It also plays an important role in bowel disease, where it may be involved in the development of chronic inflammatory bowel disease.</p>Formula:C109H159N25O32S5•(C2H4O2)xPurity:Min. 95%Molecular weight:2,491.91 g/molPRI-724
CAS:<p>PRI-724 is an investigational small molecule known as a selective inhibitor of the Wnt/β-catenin signaling pathway. It is derived from extensive research into targeting dysregulated cellular pathways implicated in oncogenesis. PRI-724 operates by binding to the transcriptional co-activator CBP, thereby disrupting the interaction between CBP and β-catenin, which is crucial for the transcription of genes involved in cell proliferation and survival.</p>Formula:C33H35N6O7PPurity:Min. 95%Molecular weight:658.6 g/mol[D-Ala2,Met5]-β-Casomorphin (1-5), bovine
<p>Catalogue peptide; min. 95% purity</p>Formula:C31H41N5O7SMolecular weight:627.78 g/molTACE (ADAM-17)
<p>Catalogue peptide; min. 95% purity</p>Formula:C75H115N24O26Molecular weight:1,768.91 g/molC-Type Natriuretic Peptide (1-53) (human)
<p>Catalogue peptide; min. 95% purity</p>Formula:C251H417N81O71S3Molecular weight:5,801.81 g/molJNJ 10397049
CAS:<p>JNJ 10397049 is a pharmacological compound categorized as a selective T-type calcium channel blocker, which is a synthetic compound designed for specific targeting of calcium channels. The product functions by inhibiting T-type calcium channels, which are voltage-gated ion channels involved in the regulation of intracellular calcium levels. This inhibition leads to a decrease in calcium influx, modulating neuronal excitability and reducing excessive neuronal firing.</p>Formula:C19H20Br2N2O3Purity:Min. 95%Molecular weight:484.18 g/molδ (Phospho) Sleep Inducing Peptide
<p>Catalogue peptide; min. 95% purity</p>Formula:C35H49N10O18PMolecular weight:928.83 g/molH-Ile-Met-OH
CAS:<p>H-Ile-Met-OH is a cytosolic protein that is found in the cytosolic domain of plant cells. H-Ile-Met-OH is an enzyme that catalyzes the conversion of HMBP to Met, which is an intermediate in the biosynthesis of methionine. The frequency and sequence of H-Ile-Met-OH has been analyzed in animals, plants, and fungi. Bioinformatics studies have shown that H-Ile-Met-OH has a vacuolar function, which can be seen by its sequence similarity to other vacuolar proteins.</p>Formula:C11H22N2O3SPurity:Min. 95%Molecular weight:262.37 g/molWWamide-2
<p>Catalogue peptide; min. 95% purity</p>Formula:C46H65N13O10SMolecular weight:992.18 g/molBiotin-IkB Inhibitor, amide
<p>Catalogue peptide; min. 95% purity</p>Formula:C63H101N21O24SMolecular weight:1,600.76 g/molSH2 Domain Ligand (3)
<p>Catalogue peptide; min. 95% purity</p>Formula:C82H122N15O27PSMolecular weight:1,813.03 g/molCl2A-SN-38
CAS:<p>Cl2A-SN-38 is an innovative antibody-drug conjugate (ADC), which is derived from a targeted delivery system designed to enhance the therapeutic index of chemotherapeutic agents. The product is synthesized through the chemical conjugation of the monoclonal antibody Cl2A with the potent topoisomerase I inhibitor, SN-38. This conjugation is achieved using a stable linker that facilitates selective delivery of SN-38 to cancer cells expressing the target antigen, thus minimizing systemic toxicity.</p>Formula:C73H97N11O22Purity:Min. 95%Molecular weight:1,480.6 g/molH-Leu-Arg-OH acetate salt
CAS:<p>H-Leu-Arg-OH acetate salt is a cyclase inhibitor that is used to treat cancer. It has been shown to inhibit soluble guanylate cyclase, which is an enzyme that converts guanosine triphosphate (GTP) into the second messenger molecule, cyclic guanosine monophosphate (cGMP). Inhibition of this enzyme results in a decrease in the production of cGMP and blood pressure. H-Leu-Arg-OH acetate salt also inhibits delta opioid receptors, which are found on the surface of cells in the brain. This drug binds competitively with delta opioid receptors and blocks the effect of endogenous or exogenous ligands such as enkephalins.</p>Formula:C12H25N5O3Purity:Min. 95%Color and Shape:PowderMolecular weight:287.36 g/molAc-Arg-Leu-Arg-AMC trifluoroacetate salt
CAS:<p>Ac-Arg-Leu-Arg-AMC trifluoroacetate salt is a mitochondrial biogenesis activator that has been shown to increase the levels of proteins in the mitochondria. These proteins are required for mitochondrial membrane potential, ATP production, and protein homeostasis. Ac-Arg-Leu-Arg-AMC trifluoroacetate salt has been shown to increase the number of pluripotency markers in human liver cells and to reduce insulin resistance in animals. The drug also increases the expression of ubiquitin ligases and proteasomes, which are enzymes that degrade damaged proteins. Ac-Arg-Leu-Arg-AMC trifluoroacetate salt may be used for treating liver diseases or disorders as well as obesity.</p>Formula:C30H46N10O6•C2HF3O2Purity:Min. 96 Area-%Color and Shape:PowderMolecular weight:756.77 g/molGastrin Releasing Peptide (1-16), human
<p>Catalogue peptide; min. 95% purity</p>Formula:C74H121N17O20SMolecular weight:1,600.9 g/molH-Arg(NO2)-OBzl p-tosylate salt
CAS:<p>Please enquire for more information about H-Arg(NO2)-OBzl p-tosylate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C13H19N5O4·C7H8O3SPurity:Min. 95%Color and Shape:SolidMolecular weight:481.52 g/molABT 494
CAS:<p>Inhibitor of Janus kinase JAK-1</p>Formula:C17H19F3N6OPurity:Min. 95%Molecular weight:380.37 g/molH-Gly-2-chlorotrityl resin (200-400 mesh) (Low Substitution)
CAS:<p>Please enquire for more information about H-Gly-2-chlorotrityl resin (200-400 mesh) (Low Substitution) including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Purity:Min. 95%Rcramp
<p>Catalogue peptide; min. 95% purity</p>Formula:C181H302N50O48Molecular weight:3,946.73 g/molEndokinin C (Human)
<p>Catalogue peptide; min. 95% purity</p>Formula:C78H123N21O20Molecular weight:1,674.98 g/molFluorescein-6-carbonyl-Leu-Glu(OMe)-Thr-DL-Asp(OMe)-fluoromethylketone
CAS:<p>Please enquire for more information about Fluorescein-6-carbonyl-Leu-Glu(OMe)-Thr-DL-Asp(OMe)-fluoromethylketone including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C43H47FN4O15Purity:Min. 95%Molecular weight:878.85 g/molTDZD 8
CAS:<p>TDZD 8 is a selective, non-ATP competitive inhibitor of the glycogen synthase kinase GSK3β. TDZD 8 inhibits GSK3β with IC50 of 2 μM and was reported to not significantly affect Cdk-1/cyclin B, casein kinase CK-II, protein kinase A and C (PKA, PKC) activities. TDZD 8 was also identified as an inhibitor of the main protease in coronaviruses. In an in vitro study, TDZD 8 was characterised as an aggregate-based inhibitor as the presence of Triton-X decreased the inhibitory potency to Mpro protease of the SARS-CoV-2 virus (IC50 without Triton-X: 2.15 μM).</p>Formula:C10H10N2O2SPurity:Min. 98 Area-%Color and Shape:PowderMolecular weight:222.26 g/molARV-471
CAS:<p>ARV-471 is an anticancer drug that acts as a Chinese hamster ovary (CHO) cell inhibitor. It is a potent and selective kinase inhibitor that has been shown to induce apoptosis in cancer cells. ARV-471 is a protein analog of nifedipine, which is a calcium channel blocker used to treat high blood pressure and angina. This drug works by inhibiting kinases, which are enzymes that regulate cellular growth and proliferation. ARV-471 has been demonstrated to be effective in treating various types of cancer, including breast cancer, by inhibiting the growth of tumor cells and inducing apoptosis. Its unique mechanism of action makes it a promising candidate for future cancer therapies.</p>Formula:C45H49N5O4Purity:Min. 95%Molecular weight:723.9 g/molNeurogranin (28-43)
<p>Catalogue peptide; min. 95% purity</p>Formula:C78H134N28O19SMolecular weight:1,800.18 g/mol[Phe22] Big Endothelin-1 (19-37), human
<p>Catalogue peptide; min. 95% purity</p>Formula:C104H152N26O26Molecular weight:2,182.53 g/molBiotin-Glucagon (1-29), bovine, human, porcine
<p>Catalogue peptide; min. 95% purity</p>Formula:C163H239N45O51S2Molecular weight:3,709.03 g/mol[D-Ser13]-Somatostatin-14
<p>Catalogue peptide; min. 95% purity</p>Formula:C76H104N18O19S2Molecular weight:1,637.91 g/molZ-Ile-His-OH
CAS:<p>Please enquire for more information about Z-Ile-His-OH including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C20H26N4O5Purity:Min. 95%Molecular weight:402.44 g/molBexagliflozin
CAS:<p>Bexagliflozin is a drug that is used to treat type II diabetes in adults. It helps to control blood sugar levels by inhibiting the enzyme DPP-IV and increasing insulin release from the pancreas. Bexagliflozin has been shown to be effective in lowering blood sugar levels in patients with chronic kidney disease and cancer, as well as those with a body mass index (BMI) of 30 or higher. This drug is an oral hypoglycaemic agent that can be used for diagnostic purposes. It has also been shown to be clinically effective for the treatment of diabetic nephropathy and diabetic retinopathy. The enantiomers of bexagliflozin can be differentiated according to their pharmacological properties, which may allow for more targeted therapy.</p>Formula:C24H29ClO7Purity:Min. 95%Molecular weight:464.94 g/molTariquidar
CAS:<p>Potent P-glycoprotein (P-gp) inhibitor</p>Formula:C38H38N4O6Purity:Min. 97 Area-%Color and Shape:PowderMolecular weight:646.73 g/molAngiotensin I/II (1-6)
CAS:<p>Angiotensin I/II 1-6 is a peptide containing amino acids 1-6; derived from from Angiotensin I/II.</p>Formula:C36H55N11O10Purity:Min. 95%Molecular weight:801.89 g/mol9-cis-Retinoic acid
CAS:Controlled Product<p>A natural metabolite of vitamin A. It is derived from all-trans retinoic acid, FR17921. It potently activates all isoforms of retinoic acid receptor (RAR) as well as retinoid X receptor (RXR) isoforms.</p>Formula:C20H28O2Purity:Min. 95%Color and Shape:PowderMolecular weight:300.44 g/molH-Glu(EDANS)-Lys-Pro-Ala-Lys-Phe-Phe-Arg-Leu-Lys(DABCYL)-NH2 trifluoroacetate salt
CAS:<p>Please enquire for more information about H-Glu(EDANS)-Lys-Pro-Ala-Lys-Phe-Phe-Arg-Leu-Lys(DABCYL)-NH2 trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C88H124N22O15SPurity:Min. 95%Molecular weight:1,762.13 g/molFluorescein-6-carbonyl-Val-Glu(OMe)-Ile-DL-Asp(OMe)-fluoromethylketone
CAS:<p>Please enquire for more information about Fluorescein-6-carbonyl-Val-Glu(OMe)-Ile-DL-Asp(OMe)-fluoromethylketone including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C44H49FN4O14Purity:Min. 95%Molecular weight:876.88 g/molCalmodulin-Dependent Protein Kinase II (290-309)
CAS:<p>Calmodulin-dependent protein kinase II (CAMKII) is a calcium/calmodulin-dependent enzyme that plays an important role in the regulation of cardiac contractility. CAMKII is activated by the binding of beta-adrenergic and other hormones to their receptors on the plasma membrane, leading to a change in the membrane potential. CAMKII then phosphorylates myofibrils, which leads to an increase in cardiac contractility. In liver cells, CAMKII activation leads to an increase in contractility and perfusion through increased ethylene production.</p>Formula:C103H185N31O24SPurity:Min. 95%Molecular weight:2,273.83 g/mol[Cys(Acm)20,31]-EGF (20-31)
<p>Catalogue peptide; min. 95% purity</p>Formula:C63H98N16O23S3Molecular weight:1,543.77 g/molC-Reactive Protein (CRP) (77-82)
<p>Catalogue peptide; min. 95% purity</p>Formula:C23H40N6O10Molecular weight:560.61 g/molP61 (343-355), M. leprae
<p>Catalogue peptide; min. 95% purity</p>Formula:C62H107N21O24Molecular weight:1,530.67 g/molrec IFN-γ (human)
CAS:Controlled Product<p>Please enquire for more information about rec IFN-gamma (human) including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Purity:Min. 95%Fluorescein-6-carbonyl-Asp(OMe)-Glu(OMe)-Val-DL-Asp(OMe)-fluoromethylketone
CAS:<p>Please enquire for more information about Fluorescein-6-carbonyl-Asp(OMe)-Glu(OMe)-Val-DL-Asp(OMe)-fluoromethylketone including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C43H45FN4O16Purity:Min. 95%Molecular weight:892.83 g/molFmoc-Phe-Wang resin (100-200 mesh)
<p>Please enquire for more information about Fmoc-Phe-Wang resin (100-200 mesh) including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Purity:Min. 95%Darexaban
CAS:<p>Darexaban is a non-peptidic, small molecule that inhibits the enzyme glucuronide conjugate. It is used to prevent and treat thrombosis and thromboembolism in patients undergoing atrial or abdominal surgery. Darexaban has been shown to be effective in the treatment of heparin-induced thrombocytopenia (HIT) by inhibiting the activation of platelets. The drug also has pharmacokinetic properties that are similar to those of heparin, such as a half-life of 5–7 hours. Darexaban also has anti-inflammatory effects, and can reduce autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis.</p>Purity:Min. 95%PRRS-PQGAB-N
<p>Catalogue peptide; min. 95% purity</p>Formula:C54H76N12O24SMolecular weight:1,309.33 g/molβ-MSH, porcine
<p>Catalogue peptide; min. 95% purity</p>Formula:C98H138N26O29SMolecular weight:2,176.36 g/molInsulin-like Growth Factor I (57-70)
<p>Catalogue peptide; min. 95% purity</p>Formula:C65H104N15O23SMolecular weight:1,495.7 g/molMyristoylated ADP-Ribosylation Factor 6, myr-ARF6 (2-13)
<p>Catalogue peptide; min. 95% purity</p>Formula:C74H128N16O18Molecular weight:1,529.95 g/molRetatrutide acetate
CAS:<p>Acetate salt; GLP-1, GIP, and GCGR2 mimic; Obesity research</p>Formula:C221H342N46O68•(C2H4O2)xMolecular weight:4,791.38 g/mol[D-Ala2, DArg6] Dynorphin A, (1-13), porcine
<p>Catalogue peptide; min. 95% purity</p>Formula:C76H128N24O15Molecular weight:1,618.02 g/mol[Pyr11]-Amyloid β-Protein (11-40)
<p>Catalogue peptide; min. 95% purity</p>Formula:C143H226N38O39SMolecular weight:3,133.71 g/mol26Rfa, Hypothalamic Peptide, frog
<p>Catalogue peptide; min. 95% purity</p>Formula:C127H197N37O36Molecular weight:2,818.21 g/molRnase (90-105)
<p>H-SKYPNCAYKTTQANKH-OH peptide, corresponding to RNase A 90-105 (Chain A of bovine pancreatic ribonuclease); min. 95% purity</p>Formula:C80H124N24O25SMolecular weight:1,854.08 g/molACTH (4-9)
<p>Catalogue peptide; min. 95% purity</p>Formula:C42H56N12O9SMolecular weight:905.05 g/mol[D-Val22] Big Endothelin-1 (16-38), human
<p>Catalogue peptide; min. 95% purity</p>Formula:C119H180N32O33Molecular weight:2,586.96 g/mol[Cys3, 6, Tyr8, Pro10]-Substance P
<p>Catalogue peptide; min. 95% purity</p>Molecular weight:1,295.6 g/molPACAP-27 (6-27) (human, chicken, mouse, ovine, porcine, rat)
CAS:<p>Catalogue peptide; min. 95% purity</p>Formula:C121H193N33O30SMolecular weight:2,638.15 g/molSALMF amide 1 (S1)
<p>Catalogue peptide; min. 95% purity</p>Formula:C41H60N10O10SMolecular weight:885.1 g/mol[Ala2] Met-Enkephalin, amide
<p>Catalogue peptide; min. 95% purity</p>Formula:C28H38N6O6SMolecular weight:586.72 g/molAngiotensinogen (1-14), human
<p>Catalogue peptide; min. 95% purity</p>Formula:C83H122N24O19Molecular weight:1,760.05 g/molBrain injury Derived Neurotrophic Peptide(3) BINP
<p>Catalogue peptide; min. 95% purity</p>Formula:C62H101N17O19Molecular weight:1,388.58 g/molMBP (1-17)
<p>Catalogue peptide; min. 95% purity</p>Formula:C79H135N27O26Molecular weight:1,879.12 g/molβ-Casomorphin, human
<p>Catalogue peptide; min. 95% purity</p>Formula:C44H61N7O11Molecular weight:864.02 g/mol[Tyr1]-δ-Sleep Inducing Peptide
<p>Catalogue peptide; min. 95% purity</p>Formula:C33H47N9O16Molecular weight:825.79 g/molBTM-P1
<p>Catalogue peptide; min. 95% purity</p>Formula:C134H219N33O31Molecular weight:2,788.44 g/molBiotin-Obestatin (rat)
<p>Catalogue peptide; min. 95% purity</p>Formula:C124H188N36O33Molecular weight:2,743.17 g/molAtrial Natriuretic Factor (4-28) (human)
<p>Catalogue peptide; min. 95% purity</p>Formula:C112H175N39O35S3Molecular weight:2,724.02 g/molAmyloid β-Protein (25-35) amide
<p>Catalogue peptide; min. 95% purity</p>Formula:C45H82N14O13SMolecular weight:1,059.31 g/molMKKp2
<p>Catalogue peptide; min. 95% purity</p>Formula:C85H158N31O26S1Molecular weight:2,062.41 g/mol[D-Ala2,DPro4,Tyr5]-β-Casomorphin (1-5), amide
<p>Catalogue peptide; min. 95% purity</p>Formula:C35H42N6O7Molecular weight:658.8 g/molα-Conotoxin MI
<p>Catalogue peptide; min. 95% purity</p>Formula:C58H92N22O17S4Molecular weight:1,497.74 g/mol[Des-Pro2] Bradykinin
<p>Catalogue peptide; min. 95% purity</p>Formula:C45H66N14O10Molecular weight:963.12 g/molRSK Substrate, S6 (231-239)
<p>Catalogue peptide; min. 95% purity</p>Formula:C45H88N22O11Molecular weight:1,113.34 g/molproPT18
<p>Catalogue peptide; min. 95% purity</p>Formula:C96H163N35O23Molecular weight:2,175.59 g/molMMP-2/MMP-9 Substrate I, fluorogenic
<p>Catalogue peptide; min. 95% purity</p>Formula:C44H61N13O13SMolecular weight:1,012.1 g/molKinase Domain of Insulin Receptor (4)
<p>Catalogue peptide; min. 95% purity</p>Formula:C72H108N19O27Molecular weight:1,702.77 g/mol[Ile76]-TNF-a (70-80) (human)
<p>Catalogue peptide; min. 95% purity</p>Formula:C55H91N15O16Molecular weight:1,218.43 g/molLys-Bradykinin-Ser-Val-Gln-Val-Ser
<p>Catalogue peptide; min. 95% purity</p>Formula:C77H121N23O20Molecular weight:1,688.96 g/molDok-4 (263-275)
<p>Catalogue peptide; min. 95% purity</p>Formula:C70H101N21O18Molecular weight:1,524.72 g/molProsaptide 769P
<p>Catalogue peptide; min. 95% purity</p>Formula:C114H194N28O35SMolecular weight:2,548.98 g/mol4A/4B, 5A/5B Peptide
<p>Catalogue peptide; min. 95% purity</p>Formula:C49H73N11O22S3Molecular weight:1,264.38 g/molZ-Leu-Leu-Arg-AMC
CAS:<p>Z-Leu-Leu-Arg-AMC is a proteolytic substrate that is used to study the activation of Th17 cells. It activates these cells by binding to the antigen peptide and protease activity, which are involved in the immune response. Z-Leu-Leu-Arg-AMC has been shown to induce autoimmune diseases in mice, as well as other conditions such as chronic inflammation and obesity. This compound also has a potential drug target for neutralizing acidity, which could be useful in treating cancer and other diseases. Z-Leu-Leu-Arg-AMC is stable at acidic pHs and can be used for biochemical studies of proteases at acidic pHs.</p>Formula:C36H49N7O7Purity:Min. 95%Color and Shape:PowderMolecular weight:691.82 g/molLF 20 Consensus Peptide. Anthrax Related Lethal Factor
<p>Catalogue peptide; min. 95% purity</p>Formula:C106H173N29O27S2Molecular weight:2,349.87 g/molZ-Leu-Tyr-chloromethylketone
CAS:<p>Z-Leu-Tyr-chloromethylketone is a peptide that binds to the reticulum and prevents the release of calcium ions. It is a chloromethyl ketone, which inhibits the L-type calcium channels in cells. Z-Leu-Tyr-chloromethylketone has been shown to block the influx of calcium ions into cytosolic compartments. This process leads to inhibition of protein synthesis and cell death by apoptosis.</p>Formula:C24H29ClN2O5Purity:Min. 95%Molecular weight:460.95 g/molMyelopeptide-2 (MP-2)
<p>Catalogue peptide; min. 95% purity</p>Formula:C41H57N7O8Molecular weight:776 g/molMMP-2/MMP-9 Inhibitor III
<p>Catalogue peptide; min. 95% purity</p>Formula:C52H73N13O14S2Molecular weight:1,168.35 g/molgp100 (639-647)
<p>Catalogue peptide; min. 95% purity</p>Formula:C47H79N15O11S2Molecular weight:1,094.36 g/molTax8, HTLV-1 (12-19)
<p>Catalogue peptide; min. 95% purity</p>Formula:C50H68N8O11Molecular weight:957.15 g/molGIP, porcine
<p>Catalogue peptide; min. 95% purity</p>Formula:C225H342N60O66SMolecular weight:4,975.66 g/molβ-Amyloid (16-26)
<p>Catalogue peptide; min. 95% purity</p>Formula:C57H86N12O17Molecular weight:1,211.39 g/molIntermedin (human)
<p>Catalogue peptide; min. 95% purity</p>Formula:C219H351N69O66S3Molecular weight:5,102.84 g/molGlucagon-Like Peptide 1, (GLP-1) amide, human
<p>Catalogue peptide; min. 95% purity</p>Formula:C184H273N51O57Molecular weight:4,111.53 g/mol[Arg91, Ala96]-MBP (87-99), human
<p>Catalogue peptide; min. 95% purity</p>Formula:C72H112N22O17Molecular weight:1,557.83 g/mol[Lys3, Phe10, Tyr13]-Autocamtide-2-Related Inhibitory Peptide (AIP) Analog
<p>Catalogue peptide; min. 95% purity</p>Formula:C74H121N23O20Molecular weight:1,652.93 g/molCys-Gly-Lys-Lys-Gly-Amyloid β-Protein (36-42)
<p>Catalogue peptide; min. 95% purity</p>Formula:C47H85N14O13SMolecular weight:1,087.35 g/mol[Tyr63] PTH (63-84), human
<p>Catalogue peptide; min. 95% purity</p>Formula:C103H172N28O37Molecular weight:2,394.68 g/molβ-Defensin-3, human
<p>Catalogue peptide; min. 95% purity</p>Formula:C216H371N75O59S6Molecular weight:5,155.22 g/molPACAP(1-38)-Lys(Biotin), amide, human, ovine, rat
<p>Catalogue peptide; min. 95% purity</p>Formula:C219H357N67O56S2Molecular weight:4,888.83 g/molBig Endothelin-1 (22-39), rat
<p>Catalogue peptide; min. 95% purity</p>Formula:C83H135N25O27Molecular weight:5,511 g/molSteroid Receptor Co-Factor Peptide
<p>Catalogue peptide; min. 95% purity</p>Formula:C79H136N26O21Molecular weight:1,786.13 g/molTransforming Growth Factor β1 Peptide, TGF-β1 (60-66), amide
<p>Catalogue peptide; min. 95% purity</p>Formula:C45H78N12O10Molecular weight:947.20 g/mol[D-Trp2] Met-Enkephalin, amide
<p>Catalogue peptide; min. 95% purity</p>Formula:C36H43N7O6SMolecular weight:701.85 g/molParathyroid Hormone (1-34)-Lys(Biotin), human
<p>Catalogue peptide; min. 95% purity</p>Formula:C197H317N59O54S3Molecular weight:4,472.26 g/molAntioxidant peptide B
<p>Catalogue peptide; min. 95% purity</p>Formula:C57H91N17O15Molecular weight:1,254.47 g/molIL-1b (208-240) (human)
<p>Catalogue peptide; min. 95% purity</p>Formula:C191H292N48O51SMolecular weight:4,108.81 g/mol[Cys0]-GTP-Binding Protein Gsa (28-42)
<p>Catalogue peptide; min. 95% purity</p>Formula:C85H143N30O24SMolecular weight:2,001.29 g/molFMRF amide Molluscan Cardioexcitatory Peptide
<p>Catalogue peptide; min. 95% purity</p>Formula:C29H42N8O4SMolecular weight:598.76 g/molEGF Receptor (988-993) (phosphorylated) (human)
<p>Catalogue peptide; min. 95% purity</p>Formula:C31H46N7O16PMolecular weight:804.7 g/molCecropin P1 (porcine)
<p>Catalogue peptide; min. 95% purity</p>Formula:C147H253N46O43Molecular weight:3,338.93 g/molCDC25C
<p>Catalogue peptide; min. 95% purity</p>Formula:C115H198N40O33SMolecular weight:2,701.17 g/molβ-Interleukin II (44-56)
<p>Catalogue peptide; min. 95% purity</p>Formula:C68H113N19O19Molecular weight:1,500.77 g/mol[Tyr22]-a-CGRP (22-37), rat
<p>Catalogue peptide; min. 95% purity</p>Formula:C82H120N20O25Molecular weight:1,785.99 g/molFibronectin Type III Connecting Segment (1-25)
<p>Catalogue peptide; min. 95% purity</p>Formula:C123H195N31O39Molecular weight:2,732.04 g/molUremic Pentapeptide (U5-Peptide)
<p>Catalogue peptide; min. 95% purity</p>Formula:C32H48N8O9Molecular weight:688.8 g/mol234 CM
<p>Catalogue peptide; min. 95% purity</p>Formula:C42H69N11O14S3Molecular weight:1,048.26 g/mol[Asp5,6,Me-Phe8] Substance P
<p>Catalogue peptide; min. 95% purity</p>Formula:C40H56N8O11SMolecular weight:857.00 g/mol[D-Met2,Pro5] Enkephalin, amide
<p>Catalogue peptide; min. 95% purity</p>Formula:C30H40N6O6SMolecular weight:612.75 g/molβ-Amyloid (12-28) - Cys
<p>Catalogue peptide; min. 95% purity</p>Formula:C92H140N26O26SMolecular weight:2,058.36 g/molLHRH, salmon
<p>Catalogue peptide; min. 95% purity</p>Formula:C60H73N15O13Molecular weight:1,212.36 g/molPeptide YY (3-36) (canine, mouse, porcine, rat)
<p>Catalogue peptide; min. 95% purity</p>Formula:C190H288N54O57Molecular weight:4,240.64 g/molGrowth Hormone Releasing Factor, GRF, (1-40), human
<p>Catalogue peptide; min. 95% purity</p>Formula:C194H317N61O63SMolecular weight:4,544.02 g/mol(Lys(Z)2)-Tuftsin
CAS:<p>Please enquire for more information about (Lys(Z)2)-Tuftsin including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C29H46N8O8Purity:Min. 95%Molecular weight:634.72 g/molSomatostatin-14 (2-9)
<p>Catalogue peptide; min. 95% purity</p>Formula:C50H67N12O10SMolecular weight:1,028.23 g/molEndothelin-1 (1-15), amide, human
<p>Catalogue peptide; min. 95% purity</p>Formula:C70H109N17O23S5Molecular weight:1,717.04 g/molLeptin (138-167) (human)
CAS:<p>Please enquire for more information about Leptin (138-167) (human) including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C141H224N37O47S2Purity:Min. 95%Molecular weight:3,253.64 g/mol
